# Bionano Genomics (BNGO) — Earnings

BNGO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bngo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.67 |
| EPS estimate | −$0.67 |
| EPS surprise | +0.00% |
| Revenue surprise | +8.20% |
| Revenue | $8.2M |
| Revenue estimate | $7.6M |
| Reported | Aug 10, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1411690/000141169026000044/bngo-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/07d2de70-f7d1-e9d4-070a-f0546b2ba312.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 10, 2026 | −$0.67 | −$0.67 | 0.00% | $7.6M | $8.2M |
| Q1 2026 | May 13, 2026 | −$0.88 | −$0.76 | 13.64% | $6.6M | $6.7M |
| Q4 2025 | Mar 23, 2026 | −$2.48 | −$1.55 | 37.37% | $7.9M | $8.0M |
| Q3 2025 | Nov 13, 2025 | −$2.08 | −$2.04 | 1.69% | $6.9M | $7.4M |
| Q2 2025 | Aug 14, 2025 | −$2.66 | −$2.00 | 24.72% | $6.6M | $6.7M |
| Q1 2025 | May 14, 2025 | −$3.02 | −$1.15 | 61.96% | $6.3M | $6.5M |
| Q4 2024 | Mar 31, 2025 | −$5.90 | −$12.14 | -105.75% | $6.0M | $8.2M |
| Q3 2024 | Nov 13, 2024 | −$11.85 | −$31.20 | -163.26% | $7.8M | $6.1M |
| Q2 2024 | Aug 7, 2024 | −$24.92 | −$14.40 | 42.21% | $8.0M | $7.8M |
| Q1 2024 | May 8, 2024 | −$38.65 | −$36.00 | 6.85% | $8.5M | $8.8M |
| Q4 2023 | Mar 5, 2024 | −$52.24 | −$66.90 | -28.06% | $10.6M | $10.7M |
| Q3 2023 | Nov 8, 2023 | −$58.18 | −$193.20 | -232.08% | $9.1M | $9.3M |
| Q2 2023 | Aug 9, 2023 | −$62.55 | −$74.40 | -18.95% | $8.3M | $8.7M |
| Q1 2023 | May 9, 2023 | −$62.72 | −$72.00 | -14.79% | $7.2M | $7.4M |
| Q4 2022 | Mar 9, 2023 | −$67.44 | −$78.00 | -15.65% | $8.1M | $8.2M |
| Q3 2022 | Nov 3, 2022 | −$68.00 | −$66.00 | 2.94% | $6.8M | $7.2M |
| Q2 2022 | Aug 4, 2022 | −$54.00 | −$66.00 | -22.22% | $6.3M | $6.7M |
| Q1 2022 | May 5, 2022 | −$44.84 | −$66.00 | -47.21% | $5.7M | $5.7M |
| Q4 2021 | Mar 1, 2022 | −$39.29 | −$48.00 | -22.18% | $5.6M | $6.3M |
| Q3 2021 | Nov 4, 2021 | −$34.55 | −$42.00 | -21.58% | $4.2M | $4.7M |

## Frequently Asked Questions

### When did Bionano Genomics (BNGO) last report earnings?

Bionano Genomics last reported on Aug 10, 2026, covering fiscal Q2 2026.

### Did BNGO beat earnings estimates?

Bionano Genomics reported EPS of −$0.67 for Q2 2026, in line with the −$0.67 consensus estimate.

### How much revenue did BNGO report last quarter?

Bionano Genomics reported $8.2M in revenue for Q2 2026, against a consensus estimate of $7.6M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).